Annual ROE
-431.87%
+252.90%+36.93%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual return on equity is -431.87%, with the most recent change of +252.90% (+36.93%) on December 31, 2023.
- During the last 3 years, AVTX annual ROE has fallen by -153.10% (-54.92%).
- AVTX annual ROE is now -610.61% below its all-time high of 84.58%, reached on December 31, 2017.
Performance
AVTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
36.88%
-119.43%-76.41%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly return on equity is 36.88%, with the most recent change of -119.43% (-76.41%) on September 30, 2024.
- Over the past year, AVTX quarterly ROE has dropped by -119.43% (-76.41%).
- AVTX quarterly ROE is now -97.37% below its all-time high of 1403.89%, reached on September 30, 2023.
Performance
AVTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.9% | -76.4% |
| 3 y3 years | -54.9% | +101.9% |
| 5 y5 years | -162.9% | +131.6% |
AVTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.9% | +36.9% | -97.4% | +101.9% |
| 5 y | 5-year | -463.0% | +36.9% | -97.4% | +101.9% |
| alltime | all time | -610.6% | +36.9% | -97.4% | +101.9% |
Avalo Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 36.88%(-76.4%) |
| Jun 2024 | - | 156.31%(-76.5%) |
| Mar 2024 | - | 664.13%(-146.1%) |
| Dec 2023 | -431.87%(-36.9%) | -1439.87%(-202.6%) |
| Sep 2023 | - | 1403.89%(+271.0%) |
| Jun 2023 | - | 378.44%(-19.5%) |
| Mar 2023 | - | 469.97%(-123.8%) |
| Dec 2022 | -684.77%(+93.3%) | -1977.87%(+378.6%) |
| Sep 2022 | - | -413.26%(-1.5%) |
| Jun 2022 | - | -419.52%(+37.9%) |
| Mar 2022 | - | -304.26%(+2.9%) |
| Dec 2021 | -354.19%(+27.1%) | -295.65%(+15.7%) |
| Sep 2021 | - | -255.48%(+11.9%) |
| Jun 2021 | - | -228.22%(+7.7%) |
| Mar 2021 | - | -211.84%(+6.9%) |
| Dec 2020 | -278.77%(+263.4%) | -198.08%(+31.9%) |
| Sep 2020 | - | -150.16%(+8.6%) |
| Jun 2020 | - | -138.24%(-1.8%) |
| Mar 2020 | - | -140.76%(+76.8%) |
| Dec 2019 | -76.71% | -79.61%(-31.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -116.90%(-46.4%) |
| Jun 2019 | - | -218.21%(+7.4%) |
| Mar 2019 | - | -203.21%(+13.7%) |
| Dec 2018 | -164.26%(-294.2%) | -178.68%(+7.7%) |
| Sep 2018 | - | -165.88%(-660.2%) |
| Jun 2018 | - | 29.61%(-54.0%) |
| Mar 2018 | - | 64.37%(-42.6%) |
| Dec 2017 | 84.58%(-134.1%) | 112.20%(-56.8%) |
| Sep 2017 | - | 259.97%(-140.8%) |
| Jun 2017 | - | -637.31%(+42.1%) |
| Mar 2017 | - | -448.45%(+3.8%) |
| Dec 2016 | -247.87%(+209.1%) | -432.16%(+64.4%) |
| Sep 2016 | - | -262.87%(-126.9%) |
| Jun 2016 | - | 978.60%(+160.8%) |
| Mar 2016 | - | 375.23%(+361.5%) |
| Dec 2015 | -80.18%(-231.5%) | 81.30%(+97.6%) |
| Sep 2015 | - | 41.15%(-45.0%) |
| Jun 2015 | - | 74.85%(+33.4%) |
| Mar 2015 | - | 56.10%(-8.0%) |
| Dec 2014 | 60.98%(-16.6%) | 60.98% |
| Dec 2013 | 73.09% | - |
FAQ
- What is Avalo Therapeutics annual return on equity?
- What is the all time high annual ROE for Avalo Therapeutics?
- What is Avalo Therapeutics annual ROE year-on-year change?
- What is Avalo Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly ROE year-on-year change?
What is Avalo Therapeutics annual return on equity?
The current annual ROE of AVTX is -431.87%
What is the all time high annual ROE for Avalo Therapeutics?
Avalo Therapeutics all-time high annual return on equity is 84.58%
What is Avalo Therapeutics annual ROE year-on-year change?
Over the past year, AVTX annual return on equity has changed by +252.90% (+36.93%)
What is Avalo Therapeutics quarterly return on equity?
The current quarterly ROE of AVTX is 36.88%
What is the all time high quarterly ROE for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly return on equity is 1403.89%
What is Avalo Therapeutics quarterly ROE year-on-year change?
Over the past year, AVTX quarterly return on equity has changed by -119.43% (-76.41%)